1179734

Ingela Danielsson, Ph.D, M.D. — FEI 3021926667

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 29, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Antonio, TX (United States)

Additional Details

Clinical BA/BE